Titan Medical Inc. (TMDI)
Total Valuation
Titan Medical has a market cap or net worth of $59.79 million. The enterprise value is $30.92 million.
| Market Cap | 59.79M |
| Enterprise Value | 30.92M |
Important Dates
The next earnings date is Wednesday, August 10, 2022, before market open.
| Estimated Earnings Date | Aug 10, 2022 |
| Ex-Dividend Date | n/a |
Share Statistics
Titan Medical has 112.19 million shares outstanding. The number of shares has increased by 178.65% in one year.
| Shares Outstanding | 112.19M |
| Shares Change (YoY) | +178.65% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 3.22% |
| Float | 111.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.98 |
| PB Ratio | 2.24 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.04, with a Debt / Equity ratio of 0.05.
| Current Ratio | 4.04 |
| Quick Ratio | 3.80 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -31.00%, which is considered low.
| Return on Equity (ROE) | -31.00% |
| Return on Assets (ROA) | -19.20% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $409,041 |
| Profits Per Employee | -$189,490 |
| Employee Count | 49 |
| Asset Turnover | 0.42 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Titan Medical has paid $56,000 in taxes.
| Income Tax | 56,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.84% in the last 52 weeks. The beta is 4.57, so Titan Medical's price volatility has been higher than the market average.
| Beta (1Y) | 4.57 |
| 52-Week Price Change | -68.84% |
| 50-Day Moving Average | 0.49 |
| 200-Day Moving Average | 0.55 |
| Average Volume (30 Days) | 234,342 |
Short Selling Information
The latest short interest is 383,330, so 0.34% of the outstanding shares have been sold short.
| Short Interest | 383,330 |
| Short % of Shares Out | 0.34% |
| Short % of Float | 0.34% |
| Short Ratio (days to cover) | 2.88 |
Income Statement
In the last 12 months, Titan Medical had revenue of $20.04 million and -9.29 million in losses. Earnings per share was -$0.08.
| Revenue | 20.04M |
| Gross Profit | 20.04M |
| Operating Income | -31.35M |
| Pretax Income | -9.23M |
| Net Income | -9.29M |
| EBITDA | -8.32M |
| EBIT | -9.09M |
| Earnings Per Share (EPS) | -$0.08 |
Balance Sheet
The company has $30.11 million in cash and $1.24 million in debt, giving a net cash position of $28.87 million or $0.26 per share.
| Cash & Cash Equivalents | 30.11M |
| Total Debt | 1.24M |
| Net Cash | 28.87M |
| Net Cash Per Share | $0.26 |
| Book Value | 26.67M |
| Book Value Per Share | 0.24 |
| Working Capital | 24.04M |
Cash Flow
In the last 12 months, operating cash flow was -$25.23 million and capital expenditures -$383,000, giving a free cash flow of -$25.62 million.
| Operating Cash Flow | -25.23M |
| Capital Expenditures | -383,000 |
| Free Cash Flow | -25.62M |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -156.42% and -46.33%.
| Gross Margin | 100.00% |
| Operating Margin | -156.42% |
| Pretax Margin | -46.05% |
| Profit Margin | -46.33% |
| EBITDA Margin | -41.49% |
| EBIT Margin | -45.33% |
| FCF Margin | -127.80% |
Dividends & Yields
Titan Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -15.53% |
| FCF Yield | -42.84% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Stock Splits
The last stock split was on June 19, 2018. It was a reverse split with a ratio of 1:30.
| Last Split Date | Jun 19, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:30 |